Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/29/2025

Investigations for Chronic Fatigue in a Young Healthy Adult with No Comorbidities

Initial Assessment

  • The American College of Oncology recommends screening for fatigue severity using a quantitative scale to determine if fatigue is mild, moderate, or severe in young healthy adults with no comorbidities 1
  • A focused fatigue history including onset, pattern, duration, changes over time, and factors that worsen or alleviate symptoms should be performed in young healthy adults with no comorbidities 1
  • The National Comprehensive Cancer Network recommends assessing impact on daily functioning and quality of life in patients with chronic fatigue 2

Laboratory Investigations

  • A complete blood count with differential should be performed to rule out anemia and assess other cell lines in young healthy adults with no comorbidities 1, 3
  • A comprehensive metabolic panel should be used to evaluate electrolytes, hepatic and renal function in young healthy adults with no comorbidities 1, 3
  • Thyroid function tests, such as TSH, should be performed to rule out hypothyroidism in young healthy adults with no comorbidities 1, 3
  • Erythrocyte sedimentation rate or C-reactive protein should be assessed to evaluate for systemic inflammation in patients with chronic fatigue 4
  • Vitamin D, iron studies, and B12 levels should be considered for testing in young healthy adults with no comorbidities 5

Assessment of Contributing Factors

  • Sleep disturbances, present in 30-75% of patients with chronic fatigue, should be evaluated in young healthy adults with no comorbidities 2
  • Emotional distress, anxiety, and depression, which commonly co-occur with fatigue, should be screened for in young healthy adults with no comorbidities 1, 2
  • Medication side effect profiles, particularly those causing sedation, should be reviewed in young healthy adults with no comorbidities 1
  • Nutritional status and recent weight changes should be assessed in young healthy adults with no comorbidities 1
  • Activity level and potential deconditioning should be evaluated in young healthy adults with no comorbidities 1, 3
  • Alcohol or substance use that may contribute to fatigue should be screened for in young healthy adults with no comorbidities 1

Additional Considerations

  • If fatigue is moderate to severe and persists despite addressing treatable factors, referral to appropriate specialists should be considered in young healthy adults with no comorbidities 1, 6

Management Approach

  • Regular physical activity with a structured exercise program is a category 1 recommendation for managing fatigue, according to the National Comprehensive Cancer Network 3, 6
  • Sleep hygiene should be addressed and any identified sleep disorders should be treated in young healthy adults with no comorbidities 2
  • Education about fatigue patterns and self-monitoring strategies should be provided to young healthy adults with no comorbidities 3, 6

Common Pitfalls to Avoid

  • Failing to recognize that fatigue may persist even after treating identifiable contributing factors should be avoided in young healthy adults with no comorbidities 4
  • Not addressing lifestyle factors such as physical activity, sleep, and stress management should be avoided in young healthy adults with no comorbidities 3

Guideline for Laboratory Evaluation of Adult Patients Presenting with Fatigue

Core Initial Laboratory Panel

  • In adults with fatigue, a focused initial panel—complete blood count with differential, comprehensive metabolic panel, and thyroid‑stimulating hormone—should be ordered to assess anemia, electrolyte/renal/hepatic status, and thyroid function, respectively. 7
  • The complete blood count with differential evaluates hemoglobin/hematocrit for anemia and examines white‑blood‑cell and platelet counts to identify hematologic abnormalities. 8
  • The comprehensive metabolic panel screens electrolytes, liver enzymes, and renal markers to detect metabolic contributors to fatigue. 8
  • Thyroid‑stimulating hormone testing screens for hypothyroidism or hyperthyroidism; abnormal results warrant further endocrinologic assessment or specialist referral. 8

Decision‑Making Based on Clinical Context

  • Laboratory testing should be driven by the presence of additional symptoms, the pattern of onset, and fatigue severity rather than by routine screening of all fatigued patients. 9
  • Evidence indicates that abnormal laboratory results alter clinical management in only about 5 % of fatigued adults; when initial tests are normal, repeat testing is generally not recommended. 9

Integration with Non‑Laboratory Management

  • A systematic clinical assessment of treatable contributors—such as pain, mood disorders, sleep disturbance, nutritional deficits, anemia, medication side effects, and comorbidities—often provides greater diagnostic value than laboratory testing alone. 9
  • The most effective overall strategy combines targeted laboratory evaluation with lifestyle interventions; structured physical‑activity programs have stronger evidence for improving fatigue than most pharmacologic treatments. 10

REFERENCES

2

nccn clinical practice guidelines cancer-related fatigue. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

6

survivorship: fatigue, version 1.2014. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2014